CREATE Medicines

Private · United States

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 1/2
Next date
MT-304, Phase 1 trial completes
Drugs
4
in active trials · 5 in all
Trials
4 active
5 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
In vivo CD19 CAR-T, mRNA in lipid nanoparticles
Phase 1/2 1 Dec 2028Phase 1/2 trial completes
—
Phase 1 31 Jan 2027Phase 1 trial completes
—
Phase 1 31 Aug 2027Phase 1 trial completes
—
Phase 1 31 Dec 2027Phase 1 trial completes

About

No active trial
MT-101
SEC filings
None: CREATE Medicines is private
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow CREATE Medicines

Following is part of Solo: you see every change to CREATE Medicines the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in